UK Markets close in 8 hrs 25 mins

Ocugen, Inc. (OCGN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1000+0.1900 (+9.95%)
At close: 04:00PM EDT
2.0800 -0.02 (-0.95%)
After hours: 07:59PM EDT
Sign in to post a message.
  • S
    STEVE
    U.S. 'Vulnerable' To COVID Without New Vaccines

    Covaxin !!!!!!!

    White House COVID-19 coordinator Dr. Ashish Jha has issued a dire warning that the U.S. will be increasingly vulnerable to the coronavirus this fall and winter if Congress doesn't swiftly approve new funding for more vaccines and treatments.
  • A
    Alex - Sans the Mercy
    Jonathan actively bragged about buying Moderna @ $450.

    His excitement for it being up to $140 is only clouded by his knowledge that he bought at it's peak, and chances are he will be waiting literally years just to break even.
  • M
    Montana J
    Voting against item 3. Salary increases/golden parachutes for exec's. Page 37 of voting prospectus. Please read...
  • 5
    55Chevy
    I truly cannot believe we are now under $2
  • b
    brock Lee
    Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine
    CEPI will fund the researchers to conduct activities including immunogen design, preclinical studies, manufacturing process development and a Phase 1 clinical trial.
  • T
    Tomáš
    Analyst Robert LeBoyer from Noble Financial reiterated a Buy rating on Ocugen (OCGN), with a $15 price target.
  • L
    Lanre
    Hope all longs took advantage of the sub- $2 dips….and if not keep those limit orders loaded. Payday for the prudently patient.
  • T
    Tony Shark
    This company has a great rep for running up just as quickly as it falls. I hope it does the same again. In the mean time vote no to pay increases
  • M
    Master
    Covaxin was mentioned on FOX NEWS. Doctor said FDA has been sitting on it for over 6 months and won't approve it. He don't understand why.
  • S
    STEVE
    Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

    Bharat Bio already looking into a COVID vaccine to cover all variants which will filter to their partner Ocugen.

    PAY-TIENCE

    Researchers to conduct activities including immunogen design, preclinical studies, manufacturing process development and a Phase 1 clinical trial.
  • S
    STEPHANIE
    As of 12 May 2022, ECDC has reclassified Omicron sub-lineages BA.4 and BA.5 from variants of interest to variants of concern.
  • V
    V
    Any stock that hasn’t bottomed in the last 1 month? C’mon
  • V
    V
    Covid Cases Surge Nationwide As White House Warns Of Potential Surge Ahead
  • G
    GIERINGER
    Guys, check out (http://Achieverspot.tech). They have been crushing it lately while OCGN barley does anything at all.
  • S
    STEPHANIE
    More and again emphasis on the Delta L452R substitution:

    BA.4 and BA.5 were first detected in South Africa in January and February 2022, respectively, and since then they have become the dominant variants there. Both lineages contain the amino-acid substitutions L452R, F486V, and R493Q in the spike receptor binding domain compared to BA.2. Preliminary studies suggest a significant change in antigenic properties of BA.4 and BA.5 compared to BA.1 and BA.2, especially compared to BA.1. Additionally, there is an increasing trend in the variant proportions for BA.5 observed in Portugal the recent weeks, accompanied by an increase in COVID-19 case numbers and test positivity rate.
  • b
    brock Lee
    Nojobnathan…
    Moderna CFO exits a day after taking charge as former employer launches probe. Reuters) -Moderna Inc's chief financial officer, Jorge Gomez, departed a day after taking charge, the vaccine maker said on Wednesday, following his former employer disclosing an internal probe related to financial reporting. Gomez's appointment was announced in April and he assumed charge on Monday. Moderna said he left on Tuesday after Dentsply Sirona Inc announced the investigation.
    The probe, which may cause a delay in the dental products maker's quarterly filing with U.S. securities regulators, was focused on the use of incentives to sell products to distributors and whether those were properly accounted. Green
  • V
    V
    South Africa’s daily coronavirus test positivity rate neared a record, rising above 30 per cent on Saturday for the first time in almost five months as two sublineages of the omicron variant spread rapidly ahead of the nation’s winter season.
  • N
    NickE21
    buy when everyone is fearful
  • o
    oliver
    30p drop in 1 day when already sub $2 is pretty painful.
  • A
    Alex - Sans the Mercy
    LMAO Jonathan out parading again - notice how when this was green yesterday he was nowhere to be found.